Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QCC0
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 7 |
GO:0005515 | protein binding | 2 | 7 |
GO:0051087 | protein-folding chaperone binding | 3 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 216 | 220 | PF00656 | 0.693 |
CLV_C14_Caspase3-7 | 226 | 230 | PF00656 | 0.647 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.525 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 185 | 187 | PF00675 | 0.413 |
CLV_NRD_NRD_1 | 272 | 274 | PF00675 | 0.360 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.381 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.505 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.318 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 272 | 274 | PF00082 | 0.350 |
CLV_PCSK_KEX2_1 | 285 | 287 | PF00082 | 0.400 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.523 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.378 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.437 |
DEG_SPOP_SBC_1 | 22 | 26 | PF00917 | 0.474 |
DOC_MAPK_DCC_7 | 286 | 296 | PF00069 | 0.607 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.715 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.449 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.698 |
DOC_USP7_UBL2_3 | 270 | 274 | PF12436 | 0.600 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.504 |
DOC_WW_Pin1_4 | 285 | 290 | PF00397 | 0.650 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.525 |
LIG_14-3-3_CanoR_1 | 97 | 106 | PF00244 | 0.727 |
LIG_BRCT_BRCA1_1 | 149 | 153 | PF00533 | 0.547 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.555 |
LIG_FHA_1 | 282 | 288 | PF00498 | 0.601 |
LIG_FHA_1 | 75 | 81 | PF00498 | 0.329 |
LIG_FHA_2 | 170 | 176 | PF00498 | 0.659 |
LIG_LIR_Gen_1 | 141 | 152 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 141 | 147 | PF02991 | 0.611 |
LIG_LIR_Nem_3 | 149 | 155 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.480 |
LIG_MLH1_MIPbox_1 | 149 | 153 | PF16413 | 0.547 |
LIG_SH2_NCK_1 | 20 | 24 | PF00017 | 0.488 |
LIG_SH2_NCK_1 | 65 | 69 | PF00017 | 0.333 |
LIG_SH2_SRC | 173 | 176 | PF00017 | 0.471 |
LIG_SH2_SRC | 63 | 66 | PF00017 | 0.383 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.333 |
LIG_SH2_STAT3 | 59 | 62 | PF00017 | 0.417 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.575 |
LIG_SH2_STAT5 | 173 | 176 | PF00017 | 0.564 |
LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.383 |
LIG_SH3_1 | 286 | 292 | PF00018 | 0.608 |
LIG_SH3_3 | 286 | 292 | PF00018 | 0.630 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.478 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.490 |
LIG_SUMO_SIM_par_1 | 72 | 79 | PF11976 | 0.308 |
LIG_UBA3_1 | 44 | 51 | PF00899 | 0.467 |
MOD_CDK_SPxxK_3 | 36 | 43 | PF00069 | 0.489 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.693 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.666 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.481 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.527 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.482 |
MOD_CK2_1 | 169 | 175 | PF00069 | 0.533 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.666 |
MOD_CMANNOS | 2 | 5 | PF00535 | 0.650 |
MOD_Cter_Amidation | 95 | 98 | PF01082 | 0.505 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.502 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.332 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.488 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.435 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.709 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.394 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.518 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.479 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.632 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.518 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.804 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.550 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.448 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.473 |
MOD_N-GLC_1 | 208 | 213 | PF02516 | 0.508 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.496 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.477 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.584 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.400 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.367 |
MOD_PIKK_1 | 249 | 255 | PF00454 | 0.524 |
MOD_PIKK_1 | 46 | 52 | PF00454 | 0.493 |
MOD_PKA_1 | 97 | 103 | PF00069 | 0.727 |
MOD_PKA_2 | 263 | 269 | PF00069 | 0.610 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.731 |
MOD_Plk_1 | 214 | 220 | PF00069 | 0.623 |
MOD_Plk_4 | 169 | 175 | PF00069 | 0.558 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.655 |
MOD_Plk_4 | 76 | 82 | PF00069 | 0.383 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.504 |
MOD_ProDKin_1 | 285 | 291 | PF00069 | 0.650 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.525 |
TRG_DiLeu_BaLyEn_6 | 163 | 168 | PF01217 | 0.564 |
TRG_DiLeu_BaLyEn_6 | 40 | 45 | PF01217 | 0.450 |
TRG_ER_diArg_1 | 156 | 158 | PF00400 | 0.521 |
TRG_ER_diArg_1 | 184 | 186 | PF00400 | 0.603 |
TRG_ER_diArg_1 | 285 | 287 | PF00400 | 0.637 |
TRG_ER_diArg_1 | 97 | 99 | PF00400 | 0.678 |
TRG_NES_CRM1_1 | 253 | 267 | PF08389 | 0.576 |
TRG_Pf-PMV_PEXEL_1 | 83 | 87 | PF00026 | 0.353 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P829 | Leptomonas seymouri | 39% | 100% |
A0A1X0NYB3 | Trypanosomatidae | 30% | 75% |
A0A3Q8IB47 | Leishmania donovani | 89% | 100% |
A4HBT9 | Leishmania braziliensis | 69% | 100% |
A4HZ86 | Leishmania infantum | 89% | 100% |
E9AV61 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |